4.1 Efficacy of GLP-1 receptor agonist therapy in SID Considering their beneficial effects on body weight, effective glycemic control, and low risk of hypoglycaemia, GLP-1 RAs may be suitable therapeutic options for SID and SIH, either as adjunctive therapy or as primary treatment
Drinking with GLP-1 isnt a simple yes or no answer but depends on how often, when, and how much someone can handle
doi: 10.3389/fnsys.2021.698240 436 JohnsonC
Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1
We always aim for the least invasive path to healing
Problem w tym, e odpowied na terapi jest bardzo zrnicowana niektrzy chudn niewiele, a zdarzaj si te osoby, ktre nie widz niemal adnych efektw